MRX(MRX)
MRX
Q3 2026 EPS Estimate
$1.26
Aug 12, 2026 · Reports before open
Revenue Estimate
$596M
FY2026E EPS$5.20
FY2027E EPS$5.78
Analyst Sentiment
Wall St. Consensus
Buy6 analysts·Limited coverage
75
Score
6 Buy (100%)0 Hold (0%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
6100%
Hold
00%
Sell
00%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price Target Expectations
Bear
$55.00
-9.8%
Consensus
$57.50
-5.7%
Bull
$60.00
-1.6%
12-Month Target Range6 analysts
$55.00$57.50$60.00
Current $60.95Consensus
Current Price
$60.95
Above Consensus
$3.45
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
Earnings & Revenue Estimates
Forward Growth Estimates (YoY)
FY2027
Rev+9.04%
EPS+11.01%
FY2028
Rev+7.09%
EPS+11.71%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $2.53B | $2.75B | $2.95B |
| Low | $2.43B | $2.65B | $2.67B |
| High | $2.62B | $2.84B | $3.14B |
| EBITDA Avg | $656M | $715M | $766M |
| Low | $630M | $689M | $694M |
| High | $682M | $739M | $816M |
| EBIT Avg | $629M | $686M | $735M |
| Low | $604M | $661M | $665M |
| High | $654M | $709M | $782M |
| Net Income Avg | $396M | $440M | $491M |
| Low | $357M | $390M | $431M |
| High | $426M | $468M | $533M |
| EPS Avg | $5.20 | $5.78 | $6.45 |
| Low | $4.69 | $5.12 | $5.66 |
| High | $5.60 | $6.15 | $7.00 |
| Analysts (Rev / EPS) | 4 / 5 | 4 / 5 | 2 / 2 |
Quarterly
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $562M | $678M | $688M | $666M | $645M | $697M | $700M | $733M |
| Low | $546M | $620M | $668M | $637M | $627M | $667M | $680M | $701M |
| High | $586M | $750M | $716M | $702M | $672M | $735M | $729M | $773M |
| EBITDA Avg | $146M | $176M | $179M | $173M | $168M | $181M | $182M | $190M |
| Low | $142M | $161M | $174M | $166M | $163M | $173M | $177M | $182M |
| High | $152M | $195M | $186M | $182M | $175M | $191M | $189M | $201M |
| EBIT Avg | $140M | $169M | $171M | $166M | $161M | $174M | $174M | $183M |
| Low | $136M | $154M | $167M | $159M | $156M | $166M | $170M | $175M |
| High | $146M | $187M | $179M | $175M | $167M | $183M | $182M | $193M |
| Net Income Avg | $87M | $111M | $106M | $109M | $107M | $113M | $110M | $122M |
| Low | $84M | $88M | $102M | $103M | $103M | $107M | $106M | $115M |
| High | $92M | $127M | $112M | $117M | $113M | $121M | $116M | $131M |
| EPS Avg | $1.15 | $1.46 | $1.39 | $1.44 | $1.40 | $1.49 | $1.44 | $1.60 |
| Low | $1.11 | $1.16 | $1.34 | $1.36 | $1.35 | $1.40 | $1.39 | $1.52 |
| High | $1.21 | $1.67 | $1.47 | $1.54 | $1.48 | $1.59 | $1.52 | $1.72 |
| Analysts (Rev / EPS) | 1 / 1 | 5 / 7 | 1 / 1 | 2 / 2 | 2 / 1 | 2 / 2 | 1 / 2 | 1 / 6 |